SERVICES

Archive | MALVERN, Pa.

Press Release: Meridia Interactive Solutions Announces Availability of TownVOTE 3.0

MALVERN, Pa., March 31, 2020 (SEND2PRESS NEWSWIRE) — Today, Meridia Interactive Solutions announced immediate availability of TownVOTE 3.0 – a proprietary electronic voting system, which allows towns, municipalities, associations, fraternal organizations, and various other government bodies to conduct safe and efficient voting in their meetings.

Continue Reading
MALVERN, Pa., Oct. 31, 2011 (SEND2PRESS NEWSWIRE) -- Reaction Biology Corporation ('RBC') today announced the publication in Nature Biotechnology, of the largest kinase profiling data set in the public domain, disclosing previously unknown kinase inhibition relationships. The data set was compiled from over 100,000 independent activity assays performed with RBC's proprietary HotSpot(SM) technology.

Reaction Biology Corporation Unveils Largest Kinase Profiling Data Set in Nature Biotechnology Publication

MALVERN, Pa., Oct. 31, 2011 (SEND2PRESS NEWSWIRE) — Reaction Biology Corporation (‘RBC’) today announced the publication in Nature Biotechnology, of the largest kinase profiling data set in the public domain, disclosing previously unknown kinase inhibition relationships. The data set was compiled from over 100,000 independent activity assays performed with RBC’s proprietary HotSpot(SM) technology.

Continue Reading
MALVERN, Pa., Oct. 24, 2011 (SEND2PRESS NEWSWIRE) -- Reaction Biology Corporation ('RBC'), a leading contract research organization providing drug discovery services in epigenetics, today announced the rollout of a new product line, recombinant proteins for epigenetic research. RBC's initial offerings will emphasize the histone methyltransferases (HMTs), including exclusive targets for which there has been no previous commercial source.

Reaction Biology Launches Recombinant Methyltransferase Line

MALVERN, Pa., Oct. 24, 2011 (SEND2PRESS NEWSWIRE) — Reaction Biology Corporation (‘RBC’), a leading contract research organization providing drug discovery services in epigenetics, today announced the rollout of a new product line, recombinant proteins for epigenetic research. RBC’s initial offerings will emphasize the histone methyltransferases (HMTs), including exclusive targets for which there has been no […]

Continue Reading

Part of the Neotrope® News Network, USA. Neotrope.net